ATAI Life Sciences (ATAI) Stock Forecast & Price Target

Compare

1,438 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ATAI Analyst Ratings

Strong Buy

8 Buy

0 Hold

0 Sell

Based on 8 analysts giving stock ratings to

ATAI

Life Sciences

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ATAI Stock 12 Month Forecast

Average Price Target

$10.86

▲(228.10%Upside)

Based on 8 Wall Street analysts offering 12 month price targets for ATAI Life Sciences in the last 3 months. The average price target is $10.86 with a high forecast of $15.00 and a low forecast of $6.00. The average price target represents a 228.10% change from the last price of $3.31.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","4":"$4","8":"$8","12":"$12","16":"$16"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$15.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":10.86,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$10.86</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$6.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,4,8,12,16],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.71,3.655384615384615,4.600769230769231,5.546153846153846,6.491538461538461,7.436923076923076,8.382307692307691,9.327692307692306,10.273076923076921,11.218461538461536,12.163846153846151,13.109230769230766,14.054615384615385,{"y":15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.71,3.336923076923077,3.963846153846154,4.59076923076923,5.217692307692307,5.844615384615384,6.471538461538461,7.098461538461538,7.725384615384614,8.35230769230769,8.979230769230767,9.606153846153845,10.233076923076922,{"y":10.86,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.71,2.963076923076923,3.216153846153846,3.4692307692307693,3.7223076923076923,3.9753846153846153,4.228461538461539,4.481538461538461,4.734615384615385,4.987692307692308,5.240769230769231,5.493846153846154,5.746923076923077,{"y":6,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.86,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.05,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.35,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.42,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.3,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.08,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.33,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.55,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.72,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.24,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.47,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.49,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.71,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$15.00

Average Price Target$10.86

Lowest Price Target$6.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$3.5

Hold

5.74%

Upside

Reiterated

07/29/25

ATAI Life Sciences demonstrates significant strengths in technical momentum and strategic initiatives through recent corporate events. However, substantial financial challenges and unattractive valuation metrics weigh on the overall score.

Patrick TrucchioH.C. Wainwright

H.C. Wainwright

$10→$15

Buy

353.17%

Upside

Reiterated

07/30/25

Atai Life Sciences price target raised to $15 from $10 at H.C. WainwrightAtai Life Sciences price target raised to $15 from $10 at H.C. Wainwright

Jay OlsonOppenheimer

Oppenheimer

$14

Buy

322.96%

Upside

Initiated

07/29/25

Atai Life Sciences initiated with an Outperform at OppenheimerAtai Life Sciences initiated with an Outperform at Oppenheimer

Michael OkunewitchMaxim Group

Maxim Group

$10

Buy

202.11%

Upside

Reiterated

07/29/25

ATAI Life Sciences: Strategic Positioning and Diversified Portfolio Drive Buy Rating

Ritu BaralTD Cowen

TD Cowen

―

Buy

―

Reiterated

07/28/25

ATAI Life Sciences (ATAI) Gets a Buy from TD Cowen

Sumant KulkarniCanaccord Genuity

Canaccord Genuity

$12→$11

Buy

232.33%

Upside

Reiterated

07/28/25

ATAI Life Sciences: Strategic Focus on BPL-003 Amid Setbacks Offers Investment Opportunity

Nathan WeinsteinAegis Capital

Aegis Capital

Buy

141.69%

Upside

Reiterated

07/02/25

Aegis Capital Remains a Buy on ATAI Life Sciences (ATAI)

Andrew TsaiJefferies

Jefferies

$5→$6

Buy

81.27%

Upside

Reiterated

07/01/25

Jefferies sees potential 50%-100% move in Atai after 'robust' depression dataJefferies sees potential 50%-100% move in Atai after 'robust' depression data

Elemer PirosLucid Capital

Lucid Capital

$12

Buy

262.54%

Upside

Initiated

06/06/25

Atai Life Sciences initiated with a Buy at Lucid CapitalAtai Life Sciences initiated with a Buy at Lucid Capital

Unknown AnalystBerenberg Bank

Not Ranked

Berenberg Bank

―

Buy

―

Initiated

04/03/25

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$3.5

Hold

5.74%

Upside

Reiterated

07/29/25

Patrick TrucchioH.C. Wainwright

H.C. Wainwright

$10→$15

Buy

353.17%

Upside

Reiterated

07/30/25

Atai Life Sciences price target raised to $15 from $10 at H.C. WainwrightAtai Life Sciences price target raised to $15 from $10 at H.C. Wainwright

Jay OlsonOppenheimer

Oppenheimer

$14

Buy

322.96%

Upside

Initiated

07/29/25

Atai Life Sciences initiated with an Outperform at OppenheimerAtai Life Sciences initiated with an Outperform at Oppenheimer

Michael OkunewitchMaxim Group

Maxim Group

$10

Buy

202.11%

Upside

Reiterated

07/29/25

ATAI Life Sciences: Strategic Positioning and Diversified Portfolio Drive Buy Rating

Ritu BaralTD Cowen

TD Cowen

―

Buy

―

Reiterated

07/28/25

ATAI Life Sciences (ATAI) Gets a Buy from TD Cowen

Sumant KulkarniCanaccord Genuity

Canaccord Genuity

$12→$11

Buy

232.33%

Upside

Reiterated

07/28/25

ATAI Life Sciences: Strategic Focus on BPL-003 Amid Setbacks Offers Investment Opportunity

Nathan WeinsteinAegis Capital

Aegis Capital

Buy

141.69%

Upside

Reiterated

07/02/25

Aegis Capital Remains a Buy on ATAI Life Sciences (ATAI)

Andrew TsaiJefferies

Jefferies

$5→$6

Buy

81.27%

Upside

Reiterated

07/01/25

Jefferies sees potential 50%-100% move in Atai after 'robust' depression dataJefferies sees potential 50%-100% move in Atai after 'robust' depression data

Elemer PirosLucid Capital

Lucid Capital

$12

Buy

262.54%

Upside

Initiated

06/06/25

Atai Life Sciences initiated with a Buy at Lucid CapitalAtai Life Sciences initiated with a Buy at Lucid Capital

Unknown AnalystBerenberg Bank

Not Ranked

Berenberg Bank

―

Buy

―

Initiated

04/03/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering ATAI Life Sciences

1 Month

xxx

Success Rate

8/12 ratings generated profit

Average Return

+4.00%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +4.00% per trade.

3 Months

xxx

Success Rate

7/12 ratings generated profit

Average Return

+16.83%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +16.83% per trade.

1 Year

Ritu BaralTD Cowen

Success Rate

8/12 ratings generated profit

Average Return

+56.53%

reiterated a buy rating 3 days ago

Copying Ritu Baral's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +56.53% per trade.

2 Years

xxx

Success Rate

11/12 ratings generated profit

Average Return

+100.83%

reiterated a xxx

rating 3 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 91.67% of your transactions generating a profit, with an average return of +100.83% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ATAI Analyst Recommendation Trends

Rating

Mar 25

Apr 25

May 25

Jun 25

Jul 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ATAI has received 21 Buy Ratings, 8 Hold Ratings, and 1 Sell Ratings. ATAI average Analyst price target in the past 3 months is 10.86.

Each month's total comprises the sum of three months' worth of ratings.

ATAI Financial Forecast

ATAI Earnings Forecast

Next quarter’s earnings estimate for ATAI is -$0.12 with a range of -$0.18 to -$0.08. The previous quarter’s EPS was -$0.15. ATAI beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.13% of the time in the same period. In the last calendar year ATAI has Outperformed its overall industry.

ATAI Sales Forecast

Next quarter’s sales forecast for ATAI is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $1.56M. ATAI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.56% of the time in the same period. In the last calendar year ATAI has Outperformed its overall industry.

ATAI Stock Forecast FAQ

What is ATAI’s average 12-month price target, according to analysts?

Based on analyst ratings, ATAI Life Sciences’s 12-month average price target is 10.86.

What is ATAI’s upside potential, based on the analysts’ average price target?

ATAI Life Sciences has 228.10% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ATAI a Buy, Sell or Hold?

ATAI Life Sciences has a consensus rating of Strong Buy which is based on 8 buy ratings, 0 hold ratings and 0 sell ratings.

What is ATAI Life Sciences’s price target?

The average price target for ATAI Life Sciences is 10.86. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $15.00 ,the lowest forecast is $6.00. The average price target represents 228.10% Increase from the current price of $3.31.

What do analysts say about ATAI Life Sciences?

ATAI Life Sciences’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of ATAI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

ATAI Life Sciences (ATAI) Stock Forecast & Price Target

ATAI Analyst Ratings

ATAI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering ATAI Life Sciences

ATAI Analyst Recommendation Trends

ATAI Financial Forecast

ATAI Earnings Forecast

ATAI Sales Forecast

ATAI Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts